Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

November 30, 1999

Study Completion Date

December 31, 2000

Conditions
AspergillosisCandidiasisFungemiaMycoses
Interventions
DRUG

FK463

DRUG

Fluconazole

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH